Vaccine blood-clot side effect puts focus on immune reactionThe pressure is on for governments that want to hasten immunizing millions of people over the next few months to understand the risk and av...
Pakistan to import Chinese Cansino COVID vaccine in bulk to package 3 million doses locally: MinisterPakistan expects to receive one million doses of Sinopharm vaccine in a couple of days.
Pakistan to start importing CanSino COVID-19 vaccine for commercial sale this weekPakistan will begin receiving shipments of China's CanSino Biologics COVID-19 vaccine this week for commercial sale, an official at the com...
Pakistan not planning to buy COVID-19 vaccines; to rely on herd immunity and donated jabsSo far, four vaccines -Sinophram (China), Oxford-AstraZeneca (UK), Sputnik-V (Russia) and Cansino Bio (China) have been registered in the c...
Pakistan approves fourth COVID-19 vaccineChinese company Cansino Biologics Inc's vaccine was approved by the Drug Regulatory Authority of Pakistan (Drap) on Friday.
Pakistan: China to gift half million doses of Sinopharm vaccine"They have said send your aircraft and airlift this vaccine immediately. So this is a happy bit of news for us, and we will hopefully be su...
China's COVID-19 vaccine makers apply to join COVAX schemeThe COVAX scheme - led by the World Health Organization and GAVI vaccine alliance - is due to start rolling out vaccines to poor and middle...
Pakistan approves initial funds to purchase COVID-19 vaccineThe initial phase of vaccinations would focus on providing free shots for frontline health workers and people above the age of 65 years, Fa...
Covid-19 vaccine front-runner held back by China’s spat with CanadaChinese customs hasn’t approved shipments of CanSino’s vaccine to Canada, the National Research Council of Canada said in a Aug. 26 email. ...
Testing of China’s candidate vaccine begins in RussiaThe Ad5-nCoV vaccine already has approval for use by China’s military after early and mid-stage trials, and further late-stage trials are b...
No country for Chinese vaccine: China's big drug maker not able to conduct overseas trialsIf history is any guide, domestic use-only could be a path for China: An Ebola vaccine, also jointly developed by CanSino and the military ...
Much headway in quest for vaccine: Drugmakers might be one step away from the Covid remedyIn the situation of a grave pandemic engulfing almost all the countries alike, hopes for a cure have brightened with encouraging developmen...
How are new vaccines developed? Here is the complete processWhat do different phases of a trial test?Phase 1 and 2 test safety and immune response. Safety is one of the most important factors in a va...
China's CanSino in talks for COVID-19 vaccine Phase III trial overseasChina's success in driving down COVID-19 infections has made it harder to conduct large-scale vaccine trials, and so far only a few countri...
'At war time speed', China leads COVID-19 vaccine raceWhile a laggard in the global vaccine industry, China, where the new coronavirus is thought to have originated, has brought state, military...
How a Chinese firm jumped to the front of the virus vaccine raceIn May, CanSino became the first globally to publish a full scientific study on its early human trials, an important step because it allows...
China's Tianjin CanSino Biotechnology to mass produce Ebola vaccineInvestment into the base totals 2 billion yuan (about USD 317 million) and construction will be complete in September, 2018.